Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Nīmes
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 74 people enrolled
- Started
- 8 Nov 2023
- Ended
- 22 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- SINTYA
- Record updated
- 13 November 2026
Who can take part
- Age
- 16 years to 25 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Diagnosis of BPD according to DSM-5 criteria and BPQ-80 scale
- High BPD severity level: ZAN-BPD (score ≥ 18/36)
- Understand, write and read French
- Be able to understand the nature, purpose and methodology of the study and agree to cooperate during evaluations
- Have signed the informed consent
- For minor patients, have signed the parental consent by at least one holder of parental authority
Who cannot take part
- Previous or current participation in specific psychotherapy for BPD
- Inclusion in a drug RIPH1 study or in a REC study (European regulation of clinical trials) for the entire duration of the study
- Lifetime diagnosis of schizoaffective disorder or schizophrenia (MINI-7)
- Refusal to participate
- Existence of a neurological pathology or cerebral sequelae of organic origin which could affect neurocognitive performance
- Intelligence quotient < 70
- Subject deprived of liberty (by judicial or administrative decision) and/or protected by law
- Inclusion in another study including psychotherapy for the duration of the study
- Subject in period of exclusion from another research protocol
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Borderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocognitive alterations linked to early trauma. The study authors hypothesize the SINTYA therapy program (one group session and one individual session weekly for 10 weeks) would reduce the level of impulsivity and clinical symptomatology (severity of the BPD; emotional regulation difficulties; dissociative symptoms; aggressiveness; ruminations; the number of self-destructive behaviors and suicidal acts; impulsive behaviors; level of suicide risk and hopelessness; the number of psychiatric hospitalizations and emergency visits for psychiatric reasons; and finally improving psychosocial functioning).
The 2 groups in the trial
- SINTYA groupTreatment being tested
Treatment: SINTYA
- ControlNo study treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder: a Study Model of Impulsivity Management
- Record updated
- 13 November 2026